A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors-Reference-Cited by-同舟云学术

A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors

Author:

Shima Midori¹,Nogami Keiji¹,Nagami Sayaka²^ORCID,Yoshida Seitaro²,Yoneyama Koichiro²^ORCID,Ishiguro Akira³^ORCID,Suzuki Takashi⁴,Taki Masashi⁵

Affiliation:

1. Department of Pediatrics Nara Medical University Kashihara Japan

2. Chugai Pharmaceutical Co., Ltd Tokyo Japan

3. Division of Hematology National Center for Child Health and Development Tokyo Japan

4. Department of Blood Coagulation Ogikubo Hospital Tokyo Japan

5. Department of Pediatrics St. Marianna University School of Medicine Kawasaki Japan

Funder

Chugai Pharmaceutical Co., Ltd

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

Reference19 articles.

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献